Bayer is signaling it has had enough of litigation, leaving the future of a crop protection tool in limbo.
Executives tell the Wall Street Journal they are nearing the end of the road for glyphosate, the main ingredient in RoundUp. CEO Bill Anderson says they are barely breaking even, and litigation costs often put them in the red.
More than 65,000 cases are pending against Bayer right now, and the company has around $16 billion set aside for settlements.
Anderson stands by glyphosate, saying it has been proven safe to use, even by the FDA. Bayer produces roughly 40 percent of the supply used by U.S. farmers.
Related Stories
Geomagnetic storms have been occurring with increased frequency in space this year, with significant consequences for agriculture.
Crop diseases and pests are taking a toll on Kansas corn. Two crop experts from Kansas State University share tips for producers dealing with cutworms and armyworms.
The Illinois Farm Bureau shows how hemp can regenerate the earth and boost rural economies.
Betsy Jibben with Ag Market Consulting takes us behind the scenes on report day with AgMarket.net.
A slimmed-down Farm Bill is back on the table in Washington, with lawmakers pushing for a deal by Fall 2025. Sen. Jerry Moran of Kansas weighs in with his outlook.
